Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557849 (1-(3-((4-((3,4-dichlorophenyl)amino)-7-methoxyquin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557865 (1-(4-((4-((3,4-dichloro- phenyl)amino)-7-methoxy- ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557852 (1-(3-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-me...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557872 (1-(4-((4-((4-bromo-3- chlorophenyl)amino)-7- metho...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557875 (1-(3-((7-methoxy-4- (phenylamino)quinazolin-6- yl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557851 (1-(3-((4-((2,4-dichlorophenyl)amino)-7-methoxyquin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557868 (1-(3-((4-((4-bromo-3- chlorophenyl)amino)-7- metho...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557873 (1-(4-((7-methoxy-4- (phenylamino)quinazolin-6- yl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557850 (6-((1-acryloylpiperidin-4-yl)oxy)-4-((3,4-dichloro...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557846 (1-(4-((4-((2,4-dichlorophenyl)amino)-7-methoxyquin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557870 (1-(3-((4-((3,4-dichloro-2- fluorophenyl)amino)-7- ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557871 (1-(3-((7-methoxy-4-((4- (trifluoromethyl)phenyl)- ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557867 (1-(4-((7-methoxy-4-((3- (oxazol-5-yl)phenyl)- amin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557866 (1-(3-((7-methoxy-4-((3- (oxazol-5-yl)phenyl)- amin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557854 (US11365189, Ex. No. 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557869 (1-(3-((4-((3-cyclopropyl- phenyl)amino)-7-methoxy-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557877 (1-(3-((7-methoxy-4-((3- (oxazol-5-yl)phenyl)- amin...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557876 (1-(3-((4-((3-chloro-4- (trifluoromethoxy)phenyl)- ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557878 (1-(3-((7-methoxy-4- (phenylamino)quinazolin-6- yl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 330 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557880 (1-(3-((4-((4-chloro-3- (hydroxymethyl)phenyl)- ami...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 480 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557881 (1-(3-((4-((4-bromo-3- chlorophenyl)amino)- pyrido[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 520 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557874 (1-(3-((4-((2,4-dichloro- phenyl)amino)-7-methoxy- ...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557848 (1-(3-((4-((2,4-dichlorophenyl)amino)pyrido[3,4-d]p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Receptor tyrosine-protein kinase erbB-2 [1-775,'VC',777-1255] (Homo sapiens (Human)) | BDBM557879 (1-(3-((7-methoxy-4-((1- methyl-1H-indazol-7-yl)- a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cell viability was determined using the Cell Titer Glo assay (Promega) as previously described. Briefly, 2000-3000 cells per well were plated in 384-... | Citation and Details BindingDB Entry DOI: 10.7270/Q2Z322V4 | |||||||||||
More data for this Ligand-Target Pair |